MedPath

CONvalescence of FUnCtional outcomes after ICU Stay by oral protein supplementation The CONFUCIUS oral protein supplementation trial

Conditions
na IC opname
intensive care
recovery post-IC
Registration Number
NL-OMON50646
Lead Sponsor
Ziekenhuisvoorzieningen Gelderse Vallei
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
72
Inclusion Criteria

1. Age >= 18 years
2. Living at home before hospital admission
3. Minimum ICU stay of 72 h
4. Informed consent

Exclusion Criteria

1. MRC sum score <= 24 or 48 >= at ICU discharge
2. Barthel Index <14 before ICU admission
3. Allergy/intolerance for study product
4. Serum creatinin > 173 mcmol/l (renal dysfunction)
5. Inclusion in other intervention trial since ICU admission
6. Inflammatory Bowel Disease
7. Zwangerschap
8. Underlying disease in which in the eyes of the attending physician, the
protein or carbohydate supplement could form a risk for the patient

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>A composite endpoint of hand grip strength, Hand-held Dynamometer m. quadriceps<br /><br>fem, Hand-held Dynamometer m. biceps brachii and 6 Minute walking test at t=2<br /><br>(hospital discharge), t=3 (day 42 = end of intervention) and t=4 (3 months<br /><br>follow-up).</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- Handgrip strength assessed with Jamar dynamometer at T=3.<br /><br>- Muscle strength leg assessed with HHD m. quadriceps fem. at T=3.<br /><br>- Muscle strength arm assessed with HHD m. biceps brachii at T=3.<br /><br>- Exercise capacity assessed with 6 Minute Walking Distance at T=3.<br /><br>- Lower extremity muscle function assessed with TCST at T=3.<br /><br>- CPAx at T=2.<br /><br>- MRCsum at T=2, T=3 and T=4.<br /><br>- Barthel score at T=3.<br /><br>- Rockwood Clinical Frailty Scale at T=3.<br /><br>- Body composition (BIA) at T=2, T=3 and T=4.<br /><br>- Plasma AA concentrations at T=3.<br /><br>- ICU readmission after ICU discharge<br /><br>- Hospital readmission after hospital discharge<br /><br>- Overall survival status </p><br>
© Copyright 2025. All Rights Reserved by MedPath